Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban for Acute DVT/PE in Japanese Patients
NCT01780987Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jan 2013
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of apixaban in deep vein thrombosis (DVT), pulmonary embolism (PE), sponsored by Pfizer. Started Jan 2013; status: completed.
02
Drugs
apixaban
03
Conditions
deep vein thrombosis (DVT)pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT01780987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01780987.